Questions remain over COX-2 advertising
Although an FDA Advisory panel has voted for Merck’s Vioxx and Pfizer’s Celebrex and Bextra to stay on the market, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.